top of page
it's where dermatology lives



Allan Ryan
Mar 18, 20242 min read
Lebrikizumab effective in patients of skin of colour with AD
Phase III results presented during a late-breaking session at the annual meeting of the American Academy of Dermatology in San Diego,...


Allan Ryan
Sep 18, 20232 min read
Studies examine optimal topical, systemic Txs for AD
Two reviews from researchers at McMaster University in Hamilton have identified the most effective topical and systemic treatments for...
Featured Posts



bottom of page